30 Pulmonary Hypertension Clinical Trials in Salt Lake City, UT (2026)

Q: How do I join a clinical trial in Salt Lake City?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Salt Lake City research site will contact you.

Recruiting Pulmonary Hypertension Studies in Salt Lake City

NCT07609394Recruiting

Duchenne Electronic Health Record Study

This study aims to collect retrospective and prospective, long-term data of patients with dystrophinopathy (including Duchenne, Becker, and female carriers) through electronic transfer. At select clin...

Salt Lake City, UT2,500 participantsThe Duchenne Registry

View Study Details

NCT06152627Recruiting

Voice Therapy Per the Rehabilitation Treatment Specification System

The goal of this study is to evaluate if using evidence-based, standard ingredient and target codes from the Rehabilitation Treatment Specification System - Voice Therapy (RTSS-Voice) in standard of c...

Salt Lake City, UTNA600 participantsMassachusetts General Hospital

View Study Details

NCT03639285Recruiting

Natural History, Diagnosis, and Outcomes for Leukodystrophies

The goals of this protocol is to diagnose, care for, and understand the clinical histories and outcomes of people with leukodystrophies....

Salt Lake City, UT600 participantsUniversity of Utah

View Study Details

NCT04763356Recruiting

Remote Monitoring and Management of Chemotherapy Induced Peripheral Neuropathy

This is a prospective randomized trial designed to investigate a new care model for patients who suffer from nerve damage from chemotherapy called chemotherapy induced peripheral neuropathy (CIPN). Al...

Salt Lake City, UTNA422 participantsUniversity of Vermont

View Study Details

NCT06628128Recruiting

A Long-Term Study of JNT-517 in Participants With Phenylketonuria

The goal of this Phase 3, open-label study is to evaluate the long-term safety of JNT-517 in pediatric and adult participants with Phenylketonuria (PKU) after completion of either Study JNT517-101 (NC...

Salt Lake City, UTPHASE3240 participantsOtsuka Pharmaceutical Development & Commercialization, Inc.

View Study Details

NCT06614322Recruiting

SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.

The goal of this clinical trial is to determine whether quantitative sensory testing (QST) can be used to classify participants into pain sub-groups and predict who will respond best to certain pain t...

Salt Lake City, UTPHASE2190 participantsUniversity of Rochester

View Study Details

NCT07502456Recruiting

Clareon TruPlus Study

The purpose of this research study is to generate safety and performance data for Clareon TruPlus Monofocal Intraocular Lenses (IOLs). IOLs are medical devices that are implanted in the eye during cat...

Salt Lake City, UTNA122 participantsAlcon Research

View Study Details

NCT05643742Recruiting

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

This is an open-label, multicenter, Phase 1/2 study evaluating the safety and efficacy of CTX112™ in subjects with relapsed or refractory B-cell malignancies....

Salt Lake City, UTPHASE1120 participantsCRISPR Therapeutics AG

View Study Details

NCT06238648Recruiting

Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy

This phase II trial compares epcoritamab to standard practice (observation) for the treatment of patients with B-cell lymphomas who are not in complete remission after treatment with CD19-directed chi...

Salt Lake City, UTPHASE2120 participantsAcademic and Community Cancer Research United

View Study Details

NCT04771572Recruiting

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

This is a Phase 1, multi-center, open-label study with a dose-escalation phase (Phase 1a) and a cohort expansion phase (Phase 1b), to evaluate the safety, tolerability, and PK profile of LP-118 under ...

Salt Lake City, UTPHASE1100 participantsNewave Pharmaceutical Inc

View Study Details

NCT07282587Recruiting

Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma

This is a two-stage Phase 2 trial evaluating the efficacy and safety of ONC206 in participants with Pheochromocytoma and Paraganglioma (PCPG)....

Salt Lake City, UTPHASE290 participantsJazz Pharmaceuticals

View Study Details

NCT04844528Recruiting

Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers

This is a randomized, phase II, double-blind, placebo-controlled trial with planned crossover to the intervention arm after 1 year. Consenting patients with CLL who have had at least one NMSC diagnos...

Salt Lake City, UTPHASE286 participantsUniversity of Utah

View Study Details

NCT05004129Recruiting

Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy

This is an open-label phase 2/3 study for individuals with Congenital Myotonic Dystrophy (Congenital DM1) who participated in the preceding AMO-02-MD-2-003 study or individuals with either Congenital ...

Salt Lake City, UTPHASE276 participantsAMO Pharma Limited

View Study Details

NCT03152058Recruiting

IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy

This treatment trial evaluates the addition of an anti-tumor necrosis factor-alpha drug, certolizumab, to usual treatment (a heparin agent and low-dose aspirin) in pregnant women with antiphospholipid...

Salt Lake City, UTPHASE255 participantsDavid Ware Branch

View Study Details

NCT05861050Recruiting

Glofitamab With Obinutuzumab, Venetoclax, and Lenalidomide for the Treatment of Patients With Newly Diagnosed High Risk Mantle Cell Lymphoma

This phase I/II trial tests the safety and effectiveness of glofitamab (with obinutuzumab pretreatment), venetoclax, and lenalidomide in treating patients with newly diagnosed, high risk mantle cell l...

Salt Lake City, UTPHASE150 participantsCity of Hope Medical Center

View Study Details

NCT06357754Recruiting

Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy

The purpose of this transgene assay testing service is to evaluate tumor samples for transgene levels in patients who received a commercially available Bristol-Myers Squibb manufactured gene modified ...

Salt Lake City, UT50 participantsBristol-Myers Squibb

View Study Details

NCT06185179Recruiting

Metformin and Muscle Recovery

A hallmark of aging is an impaired ability to adequately recover following a stressor, such as muscle disuse, resulting in muscle fibrosis and weakness thereby increasing the risk for falls and loss o...

Salt Lake City, UTEARLY_PHASE150 participantsUniversity of Utah

View Study Details

NCT05819866Recruiting

A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy

A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adults Male Subjects with Cerebral Adrenoleukodystrophy....

Salt Lake City, UTPHASE340 participantsMinoryx Therapeutics, S.L.

View Study Details

NCT07390071Recruiting

Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy

The proposed multimodal telerehabilitation model allows a rehabilitation therapy team to set up individualized rehabilitation plans using a web-based care management portal and monitor patient progres...

Salt Lake City, UTNA40 participantsUniversity of Utah

View Study Details

NCT06994845Recruiting

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN

The study is an open-label, single arm, multicenter, Phase III study to determine proteinuria reduction, pharmacokinetics (PK), safety and tolerability (including CV surveillance) of iptacopan in prim...

Salt Lake City, UTPHASE331 participantsNovartis Pharmaceuticals

View Study Details

NCT05229432Recruiting

Study of Gastric Motility in Eosinophilic Gastritis

Purpose: The study is a cross-sectional observational study designed to determine if eosinophilic gastritis (EG) results in gastric motility impairment. Hypothesis: Gastric dysfunction occurs in th...

Salt Lake City, UT30 participantsChildren's Hospital Medical Center, Cincinnati

View Study Details

NCT06788964Recruiting

Loncastuximab Tesirine and Rituximab as Bridging Therapy Before Standard-of-care CAR-T Therapy in Patients With Large B-cell Lymphoma (CORAL)

The purpose of this clinical trial is to learn if the study treatment Loncastuximab tesirine and Rituximab is safe and efficient before standard of care chimeric antigen receptor T-cell (CAR-T) therap...

Salt Lake City, UTPHASE229 participantsUniversity of Utah

View Study Details

NCT05786040Recruiting

Tafasitamab and Rituximab for Front-Line Treatment of Post-Transplant Lymphoproliferative Disorder

This phase II trial tests how well tafasitamab and rituximab work for front-line treatment of patients with post-transplant lymphoproliferative disorder. Post-transplant lymphoproliferative disorder (...

Salt Lake City, UTPHASE228 participantsTimothy Voorhees

View Study Details

NCT06390956Recruiting

Pirtobrutinib in Combination With Rituximab in Adults With Untreated Marginal Zone Lymphoma (PIONEER-MZL)

The purpose of this clinical trial is to learn if the drugs Pirtobrutinib and Rituximab are effective for the treatment of newly diagnosed marginal zone lymphoma....

Salt Lake City, UTPHASE223 participantsUniversity of Utah

View Study Details

NCT05734196Recruiting

The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency or ABCC6 Deficiency

The primary purpose of Study INZ701-104 (the ENERGY study) is to assess the safety and tolerability of INZ-701 in infants with ENPP1 Deficiency or with ABCC6 Deficiency....

Salt Lake City, UTPHASE116 participantsInozyme Pharma

View Study Details

NCT04846309Recruiting

Hypoxia Imaging for Esophageal Cancer to Guide Personalized Radiation Therapy

This is a Phase I trial evaluating the safety of personalized radiation therapy based on levels of hypoxia identified on FMISO-PET and MRI. All patients will receive a baseline FMISO positron emission...

Salt Lake City, UTPHASE116 participantsUniversity of Utah

View Study Details

NCT07528352Recruiting

External Beam Radiotherapy Followed by Bispecific Antibody Therapy for Relapsed/Refractory DLBCL

The purpose of this clinical trial is to assess the safety and tolerability of ration therapy followed by receiving epcoritamab or glofitamab in patients with relapsed/refractory diffuse large B-cell ...

Salt Lake City, UTPHASE112 participantsUniversity of Utah

View Study Details

NCT06907875Recruiting

A First-in-human Study of EPI-321 in Facioscapulohumeral Muscular Dystrophy

The goal of this clinical trial is to learn how safe and tolerable EPI-321 is and whether there may be early signs it is working in male or female adult (18 to 75 years) participants with facioscapulo...

Salt Lake City, UTPHASE112 participantsEpicrispr Biotechnologies, Inc.

View Study Details

NCT03801434Recruiting

Ruxolitinib in Treating Patients with Hypereosinophilic Syndrome or Primary Eosinophilic Disorders

This phase II trial studies how well ruxolitinib works in treating patients with hypereosinophilic syndrome or primary eosinophilic disorders....

Salt Lake City, UTPHASE210 participantsWilliam Shomali

View Study Details

NCT06227026Recruiting

Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ Malignancies

This is an open label, non-randomized, phase 1 study of anti-CD19 CAR-T cells against relapsed CD19 positive NHL, CLL and ALL based in a lymphodepletion regimen (fludarabine and cyclophosphamide) and ...

Salt Lake City, UTPHASE110 participantsUniversity of Utah

View Study Details

About Pulmonary Hypertension Clinical Trials in Salt Lake City

Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It can lead to heart failure if untreated. Treatment includes vasodilators, endothelin receptor antagonists, and PDE-5 inhibitors.

There are currently 30 pulmonary hypertension clinical trials recruiting participants in Salt Lake City, UT. These studies are seeking a combined 5,768 participants. Research is being sponsored by The Duchenne Registry, Massachusetts General Hospital, University of Utah and 19 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Hypertension Clinical Trials in Salt Lake City — FAQ

Are there pulmonary hypertension clinical trials in Salt Lake City?

Yes, there are 30 pulmonary hypertension clinical trials currently recruiting in Salt Lake City, UT. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Salt Lake City?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Salt Lake City research site will contact you about next steps.

Are clinical trials in Salt Lake City free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Salt Lake City studies also compensate for your time and travel.

What pulmonary hypertension treatments are being tested?

The 30 active trials in Salt Lake City are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary hypertension.

Data updated July 19, 2026 from ClinicalTrials.gov